IDEXX Laboratories, Inc.
One IDEXX Drive
Westbrook
Maine
04092
United States
269 articles about IDEXX Laboratories, Inc.
-
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - February 20, 2024
2/20/2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming conferences.
-
IDEXX Announces Fourth Quarter and Full Year 2023 Results
2/5/2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced fourth quarter and full year results.
-
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
1/23/2024
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, has scheduled the release of its 2023 fourth quarter and full year financial results for Monday, February 5, 2024 before the market opens.
-
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
1/12/2024
IDEXX Laboratories, Inc. announced the expansion of its Fecal Dx ® antigen testing platform with the addition of Cystoisospora.
-
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
1/12/2024
IDEXX Laboratories, Inc. announces the launch of the IDEXX inVue Dx™ Cellular Analyzer, a first-of-its-kind slide-free cellular analyzer to detect the most common cytologic changes found in ear and blood samples.
-
IDEXX Laboratories Schedules Two Institutional Investor Events
12/7/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming institutional investor events.
-
IDEXX Laboratories Announces 2023 Third Quarter Results
11/1/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results.
-
IDEXX Laboratories to Release 2023 Third Quarter Financial Results
10/5/2023
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 third quarter results for Wednesday, November 1, 2023 before the market opens.
-
IDEXX Laboratories Elects Irene Chang Britt to Board of Directors
7/12/2023
IDEXX Laboratories, Inc. today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company's Board of Directors, effective July 11, 2023.
-
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio
6/15/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced the launch of the first veterinary diagnostic test for detecting kidney injury in cats and dogs.
-
IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
5/10/2023
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023.
-
IDEXX Laboratories Announces First Quarter 2023 Results
5/2/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced first quarter results.
-
IDEXX Laboratories to Present at Two Upcoming March 2023 Institutional Investor Conferences
2/21/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, will participate in two upcoming conferences.
-
Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity
2/20/2023
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced a first-of-its-kind empirical study aimed at addressing veterinary practice capacity constraints.
-
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
2/6/2023
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results, as well as an update on U.S. companion animal diagnostic trends.
-
IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
1/26/2023
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 fourth quarter and full year financial results for Monday, February 6, 2023 before the market opens.
-
IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
12/22/2022
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023.
-
IDEXX Laboratories Announces Third Quarter 2022 Results
11/1/2022
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced third quarter results and an update on U.S. companion animal diagnostics trends.
-
IDEXX Laboratories to Release 2022 Third Quarter Financial Results
10/11/2022
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, has scheduled the release of its 2022 third quarter results for Tuesday, November 1, 2022 before the market opens.
-
IDEXX Laboratories Announces Second Quarter 2022 Results
8/2/2022
IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, announced second quarter results, as well as an update on U.S. companion animal diagnostics trends.